Boston-based life sciences investor with $2.5B raised since 2004, backing 150+ companies across oncology, immunology, rare diseases, and precision medicine. $650M Fund VII closed oversubscribed in 2022.
Learn what Omega Funds and similar investors look for:
Biotech pitch guideEdtech pitch guideFintech pitch guideTips, programs, and cultural notes
Create your pitch deck with AI, get investor-ready feedback, and find the right investors for your startup.
Get started free